130 related articles for article (PubMed ID: 8008162)
21. Preclinical assessment of an anti-EpCAM immunotoxin: locoregional delivery provides a safer alternative to systemic administration.
Brown J; Rasamoelisolo M; Spearman M; Bosc D; Cizeau J; Entwistle J; MacDonald GC
Cancer Biother Radiopharm; 2009 Aug; 24(4):477-87. PubMed ID: 19694583
[TBL] [Abstract][Full Text] [Related]
22. Immunotoxins made with a recombinant form of Pseudomonas exotoxin A that do not require proteolysis for activity.
Theuer CP; Kreitman RJ; FitzGerald DJ; Pastan I
Cancer Res; 1993 Jan; 53(2):340-7. PubMed ID: 8417828
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.
Debinski W; Karlsson B; Lindholm L; Siegall CB; Willingham MC; FitzGerald D; Pastan I
J Clin Invest; 1992 Aug; 90(2):405-11. PubMed ID: 1644913
[TBL] [Abstract][Full Text] [Related]
24. Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates.
Roffler SR; Yu MH; Chen BM; Tung E; Yeh MY
Cancer Res; 1991 Aug; 51(15):4001-7. PubMed ID: 1855216
[TBL] [Abstract][Full Text] [Related]
25. Construction of immunotoxins using Pseudomonas exotoxin A.
FitzGerald DJ
Methods Enzymol; 1987; 151():139-45. PubMed ID: 3123880
[TBL] [Abstract][Full Text] [Related]
26. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model.
Kreitman RJ; Chang CN; Hudson DV; Queen C; Bailon P; Pastan I
Int J Cancer; 1994 Jun; 57(6):856-64. PubMed ID: 8206679
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.
Batra JK; Jinno Y; Chaudhary VK; Kondo T; Willingham MC; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8545-9. PubMed ID: 2510169
[TBL] [Abstract][Full Text] [Related]
28. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis.
Fuchs HE; Archer GE; Colvin OM; Bigner SH; Schuster JM; Fuller GN; Muhlbaier LH; Schold SC; Friedman HS; Bigner DD
Cancer Res; 1990 Mar; 50(6):1954-9. PubMed ID: 2306744
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of Resistance to Immunotoxins Containing
Dieffenbach M; Pastan I
Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32630017
[TBL] [Abstract][Full Text] [Related]
30. Quantification of immunotoxin number for complete therapeutic response.
Kreitman RJ
Methods Mol Biol; 2001; 166():111-23. PubMed ID: 11217362
[No Abstract] [Full Text] [Related]
31. Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice.
Pai LH; FitzGerald DJ; Tepper M; Schacter B; Spitalny G; Pastan I
Cancer Res; 1990 Dec; 50(24):7750-3. PubMed ID: 2253218
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin.
Candiani C; Tommasi M; Fracasso G; Lorenzetti I; Adami A; Benoni G; Tridente G; Colombatti M
Life Sci; 2001 Jun; 69(3):335-46. PubMed ID: 11441924
[TBL] [Abstract][Full Text] [Related]
33. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
Reiter Y; Wright AF; Tonge DW; Pastan I
Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511
[TBL] [Abstract][Full Text] [Related]
34. Anti-transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines.
Pirker R; FitzGerald DJ; Hamilton TC; Ozols RF; Willingham MC; Pastan I
Cancer Res; 1985 Feb; 45(2):751-7. PubMed ID: 2981613
[TBL] [Abstract][Full Text] [Related]
35. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma.
Kreitman RJ; Bailon P; Chaudhary VK; FitzGerald DJ; Pastan I
Blood; 1994 Jan; 83(2):426-34. PubMed ID: 8286741
[TBL] [Abstract][Full Text] [Related]
36. A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.
Gattenlöhner S; Jörissen H; Huhn M; Vincent A; Beeson D; Tzartos S; Mamalaki A; Etschmann B; Muller-Hermelink HK; Koscielniak E; Barth S; Marx A
J Biomed Biotechnol; 2010; 2010():187621. PubMed ID: 20204062
[TBL] [Abstract][Full Text] [Related]
37. Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential.
Yu Y; Li J; Zhu X; Tang X; Bao Y; Sun X; Huang Y; Tian F; Liu X; Yang L
Int J Nanomedicine; 2017; 12():1969-1983. PubMed ID: 28331319
[TBL] [Abstract][Full Text] [Related]
38. Pseudomonas exotoxin--immunotoxins.
FitzGerald DJ; Willingham MC; Pastan I
Cancer Treat Res; 1988; 37():161-73. PubMed ID: 2908624
[TBL] [Abstract][Full Text] [Related]
39. Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice.
Bruell D; Bruns CJ; Yezhelyev M; Huhn M; Müller J; Ischenko I; Fischer R; Finnern R; Jauch KW; Barth S
Int J Mol Med; 2005 Feb; 15(2):305-13. PubMed ID: 15647848
[TBL] [Abstract][Full Text] [Related]
40. Expression cloning of cDNAs that render cancer cells resistant to Pseudomonas and diphtheria toxin and immunotoxins.
Brinkmann U; Brinkmann E; Pastan I
Mol Med; 1995 Jan; 1(2):206-16. PubMed ID: 8529099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]